Isotope analysis is the identity of isotopic signature, the distribution of certain strong isotopes and chemical elements inside chemical compounds. This may be implemented to a food internet to make it feasible to draw direct inferences concerning diet, tropic level, and subsistence. Variations in isotope ratios from isotopic fractionation are measured the use of mass spectrometry, which separates the specific isotopes of an element on the basis in their mass-to-rate ratio. Radioisotopes are radioactive isotopes of an element. Exceptional isotopes of the equal element have the same variety of protons of their atomic nuclei however differing numbers of neutrons. They also can be described as atoms that comprise an unstable mixture of neutrons and protons.
How Big is the Global Radioisotopes & Enriched Stable Isotopes Market?
The Global Radioisotopes & Enriched Stable Isotopes Market is expected to exceed more than US$ 15 billion by 2027.
The major driving factors of Global Radioisotopes & Enriched Stable Isotopes Market are as follows:
• Growing occurrence of cancer and cardiac ailments
• Increasing awareness of radiopharmaceuticals
The restraining factors of Global Radioisotopes & Enriched Stable Isotopes Market are as follows:
• High capital to bind the buying of scanners
The global radioisotopes & enriched stable isotopes market is segmented on the lines of its application, target material and regional. Based on radioisotope application segmentation it covers sterilization, food irradiation, detectors anti-static brush, nuclear batteries and agriculture. Under enriched stable isotopes application segmentation it covers nutritional research and plant based studies. Based on target material segmentation it covers accelerator isotope target and generator isotope target. The global radioisotopes & enriched stable isotopes market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the Global Market for Global Radioisotopes & Enriched Stable Isotopes Market and related technologies.
2) Analyses of global market trends, with data from 2019, estimates for 2020 and 2021, and projections of compound annual growth rates (CAGRs) through 2027.
3) Identifications of new market opportunities and targeted promotional plans for global radioisotopes & enriched stable isotopes.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for Global Radioisotopes & Enriched Stable Isotopes Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include AkzoNobel N.V., Asian Paints Ltd., Bergers Paints India Ltd., Deutsche Amphibolin-Werke Von Robert Murjahn Stiftung & Company, Diamond Vogel, DowCorning, Helios Group, KCC Corporation, Masco Corporation, PPG Industries etc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Radioisotopes & Enriched Stable Isotopes Market has been segmented as below:
By Radioisotope Application Analysis
• Sterilization
• Food irradiation
• Detectors anti-static brush
• Nuclear batteries
• Agriculture
By Enriched Stable Isotope Application Analysis
• Nutritional research
• Plant based studies
By Target Material Analysis
• Accelerator isotope target
• Generator isotope target
By Regional Analysis
• North America
• Europe
• Asia-Pacific
• Rest of the World
Reasons to Buy this Report
1) Obtain the most up to date information available on all Global Radioisotopes & Enriched Stable Isotopes Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Radioisotopes & Enriched Stable Isotopes Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Executive Summary
3 Market Overview
3.1 Introduction
3.2 Definition Of Radiopharmaceuticals
3.3 Market Segmentation
3.3.1 Radiopharmaceuticals
3.3.2 Stable Isotopes
3.4 Market Dynamics
3.4.1 Drivers
3.4.1.1 Increasing Incidence Of Cancer And Cardiac Ailments Boosts The Demand
For Radiopharmaceuticals
3.4.1.2 Increasing Use Of Spect And Pet Scans Results In Rise Of Radiopharmaceutical Usage
3.4.1.3 Rising Awareness Of Radiopharmaceuticals To Spur Growth
3.4.1.4 Ready Availability Of Radiopharmaceuticals From Cyclotrons To Goad The Growth
3.4.2 Restraints
3.4.2.1 Shorter Half-Life Of Radiopharmaceuticals Restricts The Usage
3.4.2.2 High Capital To Limit The Buying Of Scanners
3.4.2.3 Competition From Conventional Diagnostic Procedures
3.4.3 Opportunities
3.4.3.1 Potential Radioisotopes In The Pipeline
3.4.3.2 Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
3.4.3.3 Cyclotron-Based Production
3.4.3.4 Neurological Applications
3.4.4 Threat
3.4.4.1 Japanese Reactors Inefficient To Compensate The Domestic Nuclear Demand
3.5 Winning Imperatives
3.5.1 Investments On New Radioisotopes And Novel Applications
3.5.2 Shift Towards Leu-Based Mo-99 Production
3.6 Burning Issues
3.6.1 High Cost Of Pet Cameras
3.6.2 Fukushima Nuclear Disaster
3.7 Opal – A Sustainable Solution For Global Crisis In Mo-99 Supply
3.8 Regulatory Affairs
3.8.1 Japan
3.8.1.1 The Pharmaceuticals And Medical Devices Agency (PMDA, Sogo-Kiko)
3.8.2 China
3.8.2.1 China Food And Drug Administration (CFDA) & Office Of Administrative Protection
For Pharmaceuticals(OOAP)
3.8.3 India
3.8.3.1 Board Of Radiation & Isotope Technology (BRIT)
3.8.4 South Korea
3.8.4.1 Korea Institute Of Nuclear Safety (KINS) And Korea Institute Of Nuclear Nonproliferation
And Control(KINAC)
3.8.5 Malaysia
3.8.5.1 Atomic Energy Licensing Board (AELB)
3.8.6 Indonesia
3.8.6.1 Nuclear Energy Regulatory Agency (BAPETEN)
3.8.7 Australia & New Zealand
3.8.7.1 The Australian And New Zealand Society Of Nuclear Medicine (ANZSNM)
3.8.8 Roa
3.8.8.1 Dost (Philippines) & Crpns (Singapore)
3.9 Market Share Analysis
3.9.1 Radiopharmaceuticals Market
3.9.2 Enriched Stable Isotope Market
4 Asia-Pacific Radiopharmaceuticals Market, By Isotope
4.1 Introduction
4.2 Diagnostic Market
4.2.1 Opportunity Matrix
4.2.2 Single-Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
4.2.2.1 Technetium-99m (Tc-99m)
4.2.2.1.1 Tc-99m To Decide Growth Trend Of Spect Radioisotopes
4.2.2.1.2 Factors Affecting Technetium-99m Market
4.2.2.1.2.1 Technetium Can Combine With 31 Different Carrier Molecules
4.2.2.1.2.2 Sustainable Supply Of Technetium
4.2.2.2 Thallium-201 (TL-201)
4.2.2.2.1 Tl-201 Is A Potential Substitute For Tc-99m
4.2.2.3 Gallium-67 (GA-67)
4.2.2.3.1 Fluorine-18 (PET) Might Seize Ga-67 (SPECT) Market Share In The Near Future
4.2.2.4 Iodine (I-123)
4.2.2.5 Others
4.2.3 Positron-Emission Tomography (PET) Radiopharmaceuticals
4.2.3.1 Fluorine-18
4.2.3.1.1 Fdg
4.2.3.1.2 Florbetapir
4.2.3.1.3 Factors Affecting Fluorine-18 Market
4.2.3.1.3.1 Rise In Pet Procedures Increases Demand For Fdg
4.2.3.1.3.2 High Generation Costs Of Fdg
4.2.3.1.3.3 Need For Speedy & Efficient Transportation
4.2.3.2 Rubidium-82 (RB-82)
4.2.3.3 Others
4.3 Therapeutic Isotopes
4.3.1 Opportunity Matrix
4.3.2 Beta Emitters
4.3.2.1 Iodine-131 (I-131)
4.3.2.2 Yttrium-90 (Y-90)
4.3.2.2.1 Y-90 Market Influenced By Popularity Of Nordion’s Therasphere
4.3.2.3 Samarium-153 (Sm-153)
4.3.2.4 Rhenium-186 (Re-186)
4.3.2.5 Lutetium-177 (LU-177)
4.3.2.5.1 LU-177 Is A Potential Treatment Option For Neuroendocrine Cancer
4.3.2.6 Others
4.3.2.6.1 RE-188 And P-33 Are Notable Promising Isotope
4.3.3 Alpha Emitters
4.3.3.1 Radium-223 (RA-223) & Alpharadin
4.3.3.1.1 Successful Completion Of Phase Iii Trials In Men With Bone
Metastases From CRPC
4.3.3.1.2 First In-Class Alpha Pharmaceutical
4.3.3.1.3 Alpharadin Is Advantageous Over Taxotere, Beta-Therapy And Brachytherapy
4.3.3.1.4 Success Of Alpharadin
4.3.3.1.5 Porter’s Five Forces Analysis
4.3.3.1.6 Swot Analysis
4.3.3.2 Actinium-225 (AC-225)
4.3.3.3 Lead-212 (PB-212)/Bismuth-212 (BI-212)
4.3.3.4 Astatine-211 (AT-211)
4.3.3.5 Radium-224 (RA-224)
4.3.3.6 Thorium-227 (TH-227)
4.3.4 Brachytherapy
4.3.4.1 Cesium-131
4.3.4.2 Iodine-125
4.3.4.3 Palladium-103
4.3.4.4 Iridium-192
4.3.4.5 Others
5 Asia-Pacific Radiopharmaceuticals Market, By Application/Indication
5.1 Introduction
5.2 Diagnostic Application
5.2.1 Spect
5.2.1.1 Cardiology
5.2.1.2 Lymphoma
5.2.1.3 Thyroid
5.2.1.4 Neurology
5.2.1.4.1 Alzheimer’s, Dementia, And Parkinson’s Disease Driving Growth Of The
Neurology Spect Market
5.2.1.5 Others
5.2.2 Pet
5.2.2.1 Oncology
5.2.2.1.1 Fdg F-18 Has Become A Gold Standard For Oncology Diagnosis Using Pet Scan
5.2.2.2 Cardiology
5.2.2.3 Neurology
5.2.2.4 Others
5.3 Therapeutic Application
5.3.1 Thyroid
5.3.2 Bone Metastasis
5.3.3 Lymphoma
5.3.4 Endocrine Tumors
5.3.5 Others
6 Asia-Pacific Enriched Stable Isotopes Market
6.1 Introduction
6.2 Market Overview
6.3 Market Dynamics
6.3.1 Drivers
6.3.1.1 Stable Isotopes Are Natural In Origin & Hence Safe
6.3.1.2 Proteomics & System Biology, Major Factors To Boost The Growth Of Stables
6.3.1.3 Medical Applications Propel Stable Isotopes Market Growth
6.3.2 Restraints
6.3.2.1 Harmful Effects Of High Doses Of Stable Isotopes Affect Market Growth
6.3.2.2 High Cost Of Stables Isotope
6.4 Enriched Stables Market, By Isotope
6.4.1 Deuterium & O-18 Are Promising Isotopes
6.4.2 Carbon-13
6.4.3 Deuterium
6.4.4 Oxygen-18
6.4.5 Nitrogen-15
6.4.6 Other Stable Isotopes
6.5 Enriched Stables Market, By Application
6.5.1 Diagnostic & Therapy
6.5.2 Research
6.5.3 Pharmaceutical
6.5.4 Industrial Sector
7 Geographic Analysis
7.1 Introduction
7.1.1 Apac Showcases Great Scope For Market Development
7.2 Japan
7.2.1 Pet Diagnosis Increased Dramatically After 2002
7.2.2 Japanese Nuclear Market Affected By Fukushima Catastrophe In 2011
7.3 China
7.3.1 Alternative Procedures Hinder Nuclear Medicine Market
7.4 India
7.4.1 Tc-99m And F-18 Fdg, The Most Prominent Radiopharmaceuticals
7.5 South Korea
7.5.1 Nuclear Medicines Market Gained Momentum After Mid-1990s
7.6 Malaysia
7.6.1 Nuclear Medicines Market Showcased A Significant Development During The Post 1970’s Era
7.6.2 Patients Migrating To Neighboring Countries For Nuclear Medicine Services
7.7 Indonesia
7.7.1 Lack Of Skilled Professionals Affects Indonesian Nuclear Medicines Market
7.8 Australia
7.8.1 The Opal Reactor Has The Capacity To Produce Almost Half The Global Tc-99m Demand
7.8.2 Uninterrupted Mo-99 Production By Opal To Boost Tc-99m Usage
7.9 New Zealand
7.9.1 Alternative Procedures Affect Nuclear Medicines Market
7.10 Rest Of Asia (Roa)
8 Competitive Landscape
8.1 Introduction
8.2 Agreements, Partnerships, Collaborations & Joint Ventures
8.3 Products Launch
8.4 Expansions
8.5 Mergers & Acquisitions
8.6 Other Developments
9 Company Profiles
9.1 Bracco Imaging S.P.A.
9.2 Cambridge Isotope Laboratories, Inc.
9.3 Cardinal Health, Inc.
9.4 Covidien, Plc
9.5 Eczacibasi-Monrol
9.6 Fujifilm Holdings Corporation
9.7 Ge Healthcare (Subsidiary Of General Electric Company)
9.8 Iba Group
9.9 Isotec, Inc. (Sigma-Aldrich)
9.10 Lantheus Medical Imaging, Inc.
9.11 Nordion, Inc.
9.12 Ntp Radioisotopes (Pty), Ltd.
9.13 Siemens Healthcare (Subsidiary Of Siemens AG)
9.14 Taiyo Nippon Sanso Corporation
9.15 Urenco Limited
9.16 Rotem Industries, Ltd., Inc.
9.17 Australian Nuclear Association And Technology Organization (ANSTO)
9.18 Board Of Radiation And Isotope Technology (BRIT)
9.19 Institute Of Atomic Energy Polatom Radioisotope Centre
9.20 Institute Of Isotopes Co., Ltd.
9.21 Institute Of Radioelement (IRE)
The Global Radioisotopes & Enriched Stable Isotopes Market has been segmented as below:
By Radioisotope Application Analysis
• Sterilization
• Food irradiation
• Detectors anti-static brush
• Nuclear batteries
• Agriculture
By Enriched Stable Isotope Application Analysis
• Nutritional research
• Plant based studies
By Target Material Analysis
• Accelerator isotope target
• Generator isotope target
By Regional Analysis
• North America
• Europe
• Asia-Pacific
• Rest of the World
SUBSCRIBE TO OUR NEWSLETTERS
